VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Collaboration is key to making this vision a reality.

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon May 23, 2024 8:36am

40 Views

Post# 36053587

RE:Collaboration is key to making this vision a reality.

I think with the new 4.0 FDA!Also maybe moreGEHC on Ascend and ventripoint?
Ascend Cardiovascular with Ventripoint will also have the big launch mention Alvira?
On the Ventripoint testimonials website what our caregivers say about our technology "Our aim is that by working together, we can ultimately provide reliable and effective tools for clinicians on a global scale." Jeffrey Soble, MD CEO ASCEND
On the Ascend site

Open Integration with specialized AI algorithms

Seamlessly integrate specialized AI algorithms with our diagnostic viewer, InView, to improve diagnosis and monitoring of fetal, pediatric, and adult congenital heart disease
With the VentriPoint integration, generate 3D models of the heart’s chambers from Echo imaging for reproducible and accurate volumetric measurements and ejection fractions

"cardiology workflow that spans fetal, pediatric, and adult congenital procedures to provide seamless, specialized cardiac care for patients across their entire lifespan."

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver